CA2272601A1 - Peptides for inhibiting retroviruses - Google Patents

Peptides for inhibiting retroviruses Download PDF

Info

Publication number
CA2272601A1
CA2272601A1 CA002272601A CA2272601A CA2272601A1 CA 2272601 A1 CA2272601 A1 CA 2272601A1 CA 002272601 A CA002272601 A CA 002272601A CA 2272601 A CA2272601 A CA 2272601A CA 2272601 A1 CA2272601 A1 CA 2272601A1
Authority
CA
Canada
Prior art keywords
peptide
pro
seq
ser
leu
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002272601A
Other languages
English (en)
French (fr)
Inventor
Mark E. Howard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2272601A1 publication Critical patent/CA2272601A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/461—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from fish
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CA002272601A 1996-10-21 1997-10-03 Peptides for inhibiting retroviruses Abandoned CA2272601A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US73182096A 1996-10-21 1996-10-21
US08/731,820 1996-10-21
PCT/US1997/018013 WO1998017301A1 (en) 1996-10-21 1997-10-03 Peptides for inhibiting retroviruses

Publications (1)

Publication Number Publication Date
CA2272601A1 true CA2272601A1 (en) 1998-04-30

Family

ID=24941086

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002272601A Abandoned CA2272601A1 (en) 1996-10-21 1997-10-03 Peptides for inhibiting retroviruses

Country Status (6)

Country Link
US (3) US20020037326A1 (ja)
EP (1) EP0971726A4 (ja)
JP (1) JP2001503745A (ja)
AU (1) AU4809097A (ja)
CA (1) CA2272601A1 (ja)
WO (1) WO1998017301A1 (ja)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6767890B1 (en) * 1998-11-18 2004-07-27 Coastside Bio Resources Peptides having anti-cancer and anti-inflammatory activity
US20070122415A1 (en) * 2005-11-29 2007-05-31 University Of Pittsburgh Of The Commonwealth System Of Higher Education Compound and method for suppressing retroviral replication
WO2009026638A1 (en) * 2007-08-31 2009-03-05 Melbourne Health Marine-animal derived therapeutic and diagnostic agents for hepatitis b

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683221A (en) * 1986-01-09 1987-07-28 Scripps Clinic And Research Foundation Lymphocyte-activating polypeptides
WO1996003649A1 (en) * 1994-07-22 1996-02-08 The University Of North Carolina At Chapel Hill Src SH3 BINDING PEPTIDES AND METHODS OF ISOLATING AND USING SAME

Also Published As

Publication number Publication date
US20020037326A1 (en) 2002-03-28
WO1998017301A1 (en) 1998-04-30
JP2001503745A (ja) 2001-03-21
US20030091586A1 (en) 2003-05-15
AU4809097A (en) 1998-05-15
EP0971726A1 (en) 2000-01-19
US20060193847A1 (en) 2006-08-31
EP0971726A4 (en) 2002-07-24

Similar Documents

Publication Publication Date Title
US5447915A (en) Terminally blocked antiviral peptides
US6573078B1 (en) Compounds which inhibit HIV replication
US5276016A (en) Small peptides which inhibit binding to T-4 receptors and act as immunogens
US5789531A (en) Peptide-based inhibitors of HIV replication
EP0249390A2 (en) Synthetic peptides related to the HIV glycoprotein gp 120
EP0344006A2 (en) Peptides that block the binding of hiv-1 to th CD4 receptor protein
US7122193B1 (en) Retro peptides, antibodies thereto and their uses for vaccination and in vitro diagnosis
US20060193847A1 (en) Peptides for inhibiting retroviruses
US6709649B1 (en) RANTES derived peptides with anti-HIV activity
EP0462229A1 (en) Chemically modified cd4 peptide fragments having anti-retroviral properties
EP0249394B1 (en) Small peptides which inhibit binding to T-4 receptors and act as immunogens
US6827939B2 (en) Peptide having an affinity for gp120
AU2298402A (en) Peptides for inhibiting retroviruses
AU631357B2 (en) New anti-receptor peptides and therapeutic agents
US4399124A (en) Peptides having immunostimulating properties and pharmaceutical compositions containing them
DE69433057T2 (de) Peptide zur verwendung bei der impfung und induktion neutralisierender antikörper gegen das menschliche immunschwäche-virus
EP0394297A1 (en) Anti-retroviral agent
MXPA98004205A (en) Peptides for inhibiting retroviruses
JP2680011B2 (ja) Ｔ−４レセプターへの結合を阻害し免疫原として作用する小ペプチド類
WO1996038480A1 (en) Anti-inflammatory thrombospondin-derived peptides
US20040002581A1 (en) Peptides and use thereof in therapeutic agents against HIV infection
Syennerholm et al. Vahlne et al.

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued